本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2012/9/101 分钟阅读
Withdrawal of Approval of New Animal Drug Applications; Chorionic Gonadotropin; Naloxone; Oxymorphone; Oxytocin
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is withdrawing approval of four new animal drug applications (NADAs) at the sponsor's request because the products are no longer manufactured or marketed.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →